Tandem Diabetes Care, Inc.TNDMNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+6.5%
5Y CAGR+14.5%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+6.5%/yr
vs +42.5%/yr prior
5Y CAGR
+14.5%/yr
Recent deceleration
Acceleration
-36.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$468.72M+4.0%
2024$450.63M+18.6%
2023$380.03M-2.1%
2022$388.23M+18.9%
2021$326.58M+37.0%
2020$238.31M+41.8%
2019$168.09M+78.7%
2018$94.04M+48.1%
2017$63.51M+4.7%
2016$60.66M-